30
Participants
Start Date
September 5, 2024
Primary Completion Date
July 31, 2028
Study Completion Date
December 31, 2029
Tazemetostat
Treatment: On day 1 and day 15 of the first cycle, and day 1 of all following cycles, the subject will have office visit with physical exam, vital signs, and lab tests. The subject will take tazemetostat twice a day by mouth continuously as an outpatient. If continuing on the treatment for more than 6 cycles, visits change to every 3 months.
RECRUITING
University of Alabama at Birmingham, Birmingham
University of Alabama at Birmingham
OTHER